Photo of Dr. Gregory  Calip

Gregory Calip

Assistant Professor, Pharmacy Systems, Outcomes and Policy
Center Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research
Faculty and Staff Committee, Diversity & Inclusion


Building & Room:

Room 287C, College of Pharmacy


833 South Wood Street, Chicago, IL, 60612

Office Phone:

(312) 355-5318


Research Interests: Dr. Gregory Calip is associate professor in the Department of Pharmacy Systems, Outcomes and Policy, Center for Pharmacoepidemiology and Pharmacoeconomic Research at the University of Illinois at Chicago (UIC). He is an alumnus of the UIC College of Pharmacy where he completed his PharmD before pursuing his MPH in Biostatistics at New York University and PhD in Epidemiology at the University of Washington. He completed additional training in cancer epidemiology and prevention as postdoctoral fellow at the Fred Hutchinson Cancer Research Center in Seattle. Dr. Calip’s primary research interests are related to comorbidity and treatment-related sequelae among cancer survivors.

Dr. Calip is recipient of the Hans W. Vahlteich Research Scholar Award and has received grants from the National Institutes of Health, National Heart, Lung and Blood Institute and National Center for Advancing Translational Sciences to support his research on cancer treatment-related cardiotoxicity. He serves as a Consulting Editor for Clinical Therapeutics and was previously Associate Editor for Clinical Case Reports and served on the Editorial Advisory Board of the Journal of the American Pharmacists Association.
Teaching Interests: Epidemiologic Methods, Clinical Epidemiology

Selected Publications

  • Calip GS, Patel PR, Sweiss KI, Wu Z, Zhou J, Asfaw AA, Adimadhyam S, Lee TA, Chiu BC. Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma.. International journal of cancer. 2020;147(5):1300-1305. doi:10.1002/ijc.32891.
  • Zhou J, Calip GS, Rowan S, McGregor JC, Perez RI, Evans CT, Gellad WF, Suda K. Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data.. Pharmacotherapy. 2020;. doi:10.1002/phar.2452.
  • Christian S, Arain S, Patel P, Khan I, Calip GS, Agrawal V, Sweiss KI, Griffin S, Cahill K, Konig H, Esen A, Shergill A, Odenike O, Stock W, Quigley JG. A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.. American journal of hematology. 2020;95(8):937-943. doi:10.1002/ajh.25838.
  • Lee I, Jokinen JD, Crawford SY, Calip GS, Kilpatrick RD, Lee TA. Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance.. Therapeutic innovation & regulatory science. 2020;. doi:10.1007/s43441-020-00199-z.
  • Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Perreira KM, Calip GS, Nutescu EA, Gallo LC, Castaneda SF, Gonzalez F, 2nd D, Qato . Immigration Status and Disparities in the Treatment of Cardiovascular Disease Risk Factors in the Hispanic Community Health Study/Study of Latinos (Visit 2, 2014-2017).. American journal of public health. 2020;:e1-e8. doi:10.2105/AJPH.2020.305745.
  • Lee I, Lee TA, Crawford SY, Kilpatrick RD, Calip GS, Jokinen JD. Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance.. Expert opinion on drug safety. 2020;. doi:10.1080/14740338.2020.1792883.
  • Patel PR, Senyuk V, Sweiss KI, Calip GS, Pan D, Rodriguez N, Oh A, Mahmud N, Rondelli D. PARP Inhibition Synergizes with Melphalan but Does not Reverse Resistance Completely.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020;26(7):1273-1279. doi:10.1016/j.bbmt.2020.03.008.
  • Nabulsi NA, Alobaidi A, Talon B, Asfaw AA, Zhou J, Sharp L, Sweiss KI, Patel PR, Ko NY, Chiu BC, Calip GS. Self-reported health and survival in older patients diagnosed with multiple myeloma.. Cancer causes & control : CCC. 2020;31(7):641-650. doi:10.1007/s10552-020-01305-0.
  • Sweiss KI, Calip GS, Holden J, Lewkowski P, Mialik I, Johnson JJ, Galvin JP, Rondelli D, Patel P. Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2020;:1078155220927436. doi:10.1177/1078155220927436.
  • Zhou J, Nutescu EA, Han J, Calip GS. Clinical trajectories, healthcare resource use, and costs of long-term hematopoietic stem cell transplantation survivors: a latent class analysis.. Journal of cancer survivorship : research and practice. 2020;14(3):294-304. doi:10.1007/s11764-019-00842-1.
  • Kaplan HG, Calip GS, Malmgren JA. Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders.. The oncologist. 2020;25(5):391-397. doi:10.1634/theoncologist.2019-0099.
  • Sweiss KI, Vemu B, Hofmeister CC, Wenzler E, Calip GS, Galvin JP, Mahmud N, Rondelli D, Johnson JJ, Patel P. Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant.. British journal of clinical pharmacology. 2020;. doi:10.1111/bcp.14308.
  • Augusto O, Stergachis A, Dellicour S, Tinto H, Valá A, Ruperez M, Macete E, Nakanabo-Diallo S, Kazienga A, Valéa I, d’Alessandro U, Ter Kuile FO, Calip GS, Ouma P, Desai M, Sevene E. First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age.. Malaria journal. 2020;19(1):144. doi:10.1186/s12936-020-03210-y.
  • Suda K, Zhou J, Rowan SA, McGregor JC, Perez RI, Evans CT, Gellad WF, Calip GS. Overprescribing of Opioids to Adults by Dentists in the U.S., 2011-2015.. American journal of preventive medicine. 2020;58(4):473-486. doi:10.1016/j.amepre.2019.11.006.
  • Sweiss KI, Calip GS, Wirth SM, Rondelli D, Patel P. Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician-pharmacist clinic.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2020;26(3):536-542. doi:10.1177/1078155219851550.
  • Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Calip GS, Nutescu EA, Qato D. Citizenship Status and the Prevalence, Treatment, and Control of Cardiovascular Disease Risk Factors Among Adults in the United States, 2011-2016.. Circulation. Cardiovascular quality and outcomes. 2020;13(3):e006215. doi:10.1161/CIRCOUTCOMES.119.006215.
  • Patel H, Calip GS, DiDomenico RJ, Schumock GT, Suda K, Lee TA. Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms.. Pharmacotherapy. 2020;40(2):107-115. doi:10.1002/phar.2355.
  • Malmgren JA, Calip GS, Atwood MK, Mayer M, Kaplan HG. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.. Cancer. 2020;126(2):390-399. doi:10.1002/cncr.32531.
  • Ko NY, Hong S, Winn RA, Calip GS. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer.. JAMA oncology. 2020;. doi:10.1001/jamaoncol.2019.5672.
  • Sweiss KI, Lee J, Mahmud N, Calip GS, Park Y, Mahmud D, Rondelli D, Patel PR. Combined immune score of lymphocyte to monocyte ratio and immunoglobulin levels predicts treatment-free survival of multiple myeloma patients after autologous stem cell transplant.. Bone marrow transplantation. 2020;55(1):199-206. doi:10.1038/s41409-019-0681-3.
  • Grossman S, Nathan JP, Ipema HJ, Ness GL, Tierno HE, Gabay MP, Calip GS. Survey of drug information centers in the United States-2018.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2020;77(1):33-38. doi:10.1093/ajhp/zxz267.
  • Alobaidi A, Nabulsi NA, Talon B, Asfaw AA, Zhou J, Sharp L, Sweiss KI, Patel PR, Ko NY, Chiu BC, Calip GS. Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2019;. doi:10.1007/s00520-019-05246-6.
  • Willey C, Calip GS. (2019). How Did Research on Medication Safety in Pregnancy Define, Develop and Advance the Field of Pharmacoepidemiology?. Clinical therapeutics. Vol. 41. Issue 12. Page(s) 2464-2466.
  • Sweiss KI, Calip GS, Johnson JJ, Rondelli D, Patel PR. Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma.. Bone marrow transplantation. 2019;54(12):2081-2087. doi:10.1038/s41409-019-0628-8.
  • Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT. Sodium-glucose co-transporter 2 inhibitors and the risk of fractures: A propensity score-matched cohort study.. Pharmacoepidemiology and drug safety. 2019;28(12):1629-1639. doi:10.1002/pds.4900.
  • Guadamuz JS, Ozenberger K, Qato D, Ko NY, Saffore CD, Adimadhyam S, Cha AS, Moran KM, Sweiss KI, Patel PR, Chiu BC, Calip GS. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults.. Medicine. 2019;98(46):e17960. doi:10.1097/MD.0000000000017960.
  • Zueger PM, Holmes HM, Calip GS, Qato D, Pickard AS, Lee TA. Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission.. Journal of general internal medicine. 2019;34(10):2029-2037. doi:10.1007/s11606-019-05152-x.
  • Lee I, Adimadhyam S, Nutescu EA, Zhou J, Asfaw AA, Sweiss KI, Patel PR, Calip GS. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.. Pharmacotherapy. 2019;39(9):921-928. doi:10.1002/phar.2310.
  • Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS. (2019). Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Response to Skinner et al.. British journal of haematology. Vol. 186. Issue 5. Page(s) 782-783.
  • Sweiss KI, Oh A, Calip GS, Rondelli D, Patel P. Superior Survival in African American Patients Who Underwent Autologous Stem Cell Transplantation for Multiple Myeloma.. Clinical lymphoma, myeloma & leukemia. 2019;19(8):e506-e511. doi:10.1016/j.clml.2019.04.019.
  • Kaplan HG, Malmgren JA, Calip GS. Granulocyte Colony-Stimulating Factors in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia.. JAMA oncology. 2019;5(7):1065-1066. doi:10.1001/jamaoncol.2019.0737.
  • Sweiss KI, Calip GS, Oh AL, Rondelli D, Patel PR. Renal dysfunction within 90 days of FluBu4 predicts early and late mortality.. Bone marrow transplantation. 2019;54(7):980-986. doi:10.1038/s41409-018-0361-8.
  • Suda K, Calip GS, Zhou J, Rowan S, Gross AE, Hershow RC, Perez RI, McGregor JC, Evans CT. Assessment of the Appropriateness of Antibiotic Prescriptions for Infection Prophylaxis Before Dental Procedures, 2011 to 2015.. JAMA network open. 2019;2(5):e193909. doi:10.1001/jamanetworkopen.2019.3909.
  • Suda K, Durkin MJ, Calip GS, Gellad WF, Kim H, Lockhart PB, Rowan SA, Thornhill MH. Comparison of Opioid Prescribing by Dentists in the United States and England.. JAMA network open. 2019;2(5):e194303. doi:10.1001/jamanetworkopen.2019.4303.
  • Calip GS, Yu O, Boudreau DM, Shao H, Oratz R, Richardson SB, Gold HT. Diabetes and differences in detection of incident invasive breast cancer.. Cancer causes & control : CCC. 2019;30(5):435-441. doi:10.1007/s10552-019-01166-2.
  • Viner M, Zhou J, Allison D, Han J, Molokie RE, Jain S, Gowhari M, Gordeuk VR, Calip GS, Saraf SL. (2019). The morbidity and mortality of end stage renal disease in sickle cell disease.. American journal of hematology. Vol. 94. Issue 5. Page(s) E138-E141.
  • Saffore CD, Ko NY, Holmes HM, Patel PR, Sweiss KI, Adimadhyam S, Chiu BC, Calip GS. (2019). Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia.. Journal of geriatric oncology. Vol. 10. Issue 3. Page(s) 510-513.
  • Calip GS, Moran KM, Sweiss KI, Patel PR, Wu Z, Adimadhyam S, Lee TA, Ko NY, Quigley JG, Chiu BC. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma.. Cancer. 2019;125(7):1143-1154. doi:10.1002/cncr.31914.
  • Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS. Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.. British journal of haematology. 2019;185(1):116-127. doi:10.1111/bjh.15773.
  • Zhou J, Han J, Nutescu EA, Patel PR, Sweiss KI, Calip GS. Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6-Year Propensity Score-Matched Cohort Study.. Pharmacotherapy. 2019;39(1):55-66. doi:10.1002/phar.2197.
  • Adimadhyam S, Schumock GT, Calip GS, Smith Marsh DE, Layden BT, Lee TA. Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysis.. British journal of clinical pharmacology. 2019;85(1):160-168. doi:10.1111/bcp.13782.
  • Zueger PM, Holmes HM, Qato D, Pickard AS, Calip GS, Lee TA. Use of Nonpalliative Medications Following Burdensome Health Care Transitions in Hospice Patients: A Matched Cohort Analysis.. Medical care. 2019;57(1):13-20. doi:10.1097/MLR.0000000000001008.
  • Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT. Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort study.. Diabetes, obesity & metabolism. 2018;20(12):2792-2799. doi:10.1111/dom.13459.
  • Sweiss KI, Oh A, Calip GS, Rondelli D, Patel P. (2018). Similar survival but increased toxicity with a sequential versus concurrent FluBu4 regimen.. Bone marrow transplantation. Vol. 53. Issue 9. Page(s) 1221-1224.
  • Calip GS, Patel PR, Adimadhyam S, Xing S, Wu Z, Sweiss KI, Schumock GT, Lee TA, Chiu BC. Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions.. International journal of cancer. 2018;143(5):1062-1071. doi:10.1002/ijc.31407.
  • Han J, Zhou J, Kondragunta V, Zhang X, Molokie RE, Gowhari M, Hassan J, Jain S, Calip GS, Gordeuk VR, Saraf SL. (2018). Erythropoiesis-stimulating agents in sickle cell anaemia.. British journal of haematology. Vol. 182. Issue 4. Page(s) 602-605.
  • Zhou J, Han J, Nutescu EA, Gordeuk VR, Saraf SL, Calip GS. Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study.. British journal of haematology. 2018;182(2):259-270. doi:10.1111/bjh.15396.
  • Xing S, Kim S, Schumock GT, Touchette D, Calip GS, Leow AD, Lee TA. Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies.. The primary care companion for CNS disorders. 2018;20(3). doi:10.4088/PCC.17m02220.
  • Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS. Characterization of opioid use in sickle cell disease.. Pharmacoepidemiology and drug safety. 2018;27(5):479-486. doi:10.1002/pds.4291.
  • Zueger PM, Holmes HM, Calip GS, Qato D, Pickard AS, Lee TA. Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice.. Journal of the American Geriatrics Society. 2018;66(5):937-944. doi:10.1111/jgs.15328.
  • Xing S, Calip GS, Leow AD, Kim S, Schumock GT, Touchette D, Lee TA. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.. Journal of diabetes and its complications. 2018;32(5):492-500. doi:10.1016/j.jdiacomp.2017.12.008.
  • Lee WJ, Lee TA, Calip GS, Suda K, Briars LA, Schumock GT. Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.. Inflammatory bowel diseases. 2018;24(4):883-891. doi:10.1093/ibd/izx080.
  • Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Predicting Acute Exacerbations in Chronic Obstructive Pulmonary Disease.. Journal of managed care & specialty pharmacy. 2018;24(3):265-279. doi:10.18553/jmcp.2018.24.3.265.
  • Lee WJ, Lee TA, Suda K, Calip GS, Briars LA, Schumock GT. Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis.. Rheumatology (Oxford, England). 2018;57(2):273-282. doi:10.1093/rheumatology/kex049.
  • Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β2-Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid.. The Annals of pharmacotherapy. 2017;51(11):945-953. doi:10.1177/1060028017719716.
  • Calip GS, Adimadhyam S, Xing S, Rincon JC, Lee WJ, Anguiano RH. Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions.. Seminars in arthritis and rheumatism. 2017;47(2):157-164. doi:10.1016/j.semarthrit.2017.03.010.
  • Abhyankar N, Hoskins KF, Abern MR, Calip GS. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer – a SEER analysis.. BMC cancer. 2017;17(1):659. doi:10.1186/s12885-017-3640-7.
  • Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Manyando C, Rulisa S, Desai M, Ouma P, Oneko M, Vala A, Rupérez M, Macete E, Menéndez C, Nakanabo-Diallo S, Kazienga A, Valéa I, Calip GS, Augusto O, Genton B, Njunju EM, Moore KA, d’Alessandro U, Nosten F, Ter Kuile F, Stergachis A. First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies.. PLoS medicine. 2017;14(5):e1002290. doi:10.1371/journal.pmed.1002290.
  • Calip GS, Xing S, Jun DH, Lee WJ, Hoskins KF, Ko NY. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer.. Journal of oncology practice. 2017;13(5):e451-e462. doi:10.1200/JOP.2016.018317.
  • Wirtz HS, Calip GS, Buist DSM , Gralow JR, Barlow WE, Gray S, Boudreau DM. Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.. American journal of epidemiology. 2017;185(8):661-672. doi:10.1093/aje/kww242.
  • Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Comparative Effectiveness of Long-Acting Beta2 -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease.. Pharmacotherapy. 2017;37(4):447-455. doi:10.1002/phar.1913.
  • Calip GS, Elmore JG, Boudreau DM. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.. Breast cancer research and treatment. 2017;161(1):161-172. doi:10.1007/s10549-016-4043-1.
  • Lee WJ, Briars LA, Lee TA, Calip GS, Suda K, Schumock GT. Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.. Pharmacotherapy. 2016;36(12):1201-1209. doi:10.1002/phar.1856.
  • Lee WJ, Briars LA, Lee TA, Calip GS, Suda K, Schumock GT. Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease.. Inflammatory bowel diseases. 2016;22(10):2410-7. doi:10.1097/MIB.0000000000000880.
  • Malmgren JA, Calip GS, Pyott SM, Atwood MK, Kaplan HG. Therapy-related myelodysplastic syndrome following primary breast cancer.. Leukemia research. 2016;47:178-84. doi:10.1016/j.leukres.2016.06.005.
  • Calip GS, Yu O, Elmore JG, Boudreau DM. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.. Cancer causes & control : CCC. 2016;27(5):709-20. doi:10.1007/s10552-016-0744-3.
  • Dellicour S, Aol G, Ouma P, Yan N, Bigogo G, Hamel MJ, Burton DC, Oneko M, Breiman RF, Slutsker L, Feikin D, Kariuki S, Odhiambo F, Calip GS, Stergachis A, Laserson KF, ter Kuile FO, Desai M. Weekly miscarriage rates in a community-based prospective cohort study in rural western Kenya.. BMJ open. 2016;6(4):e011088. doi:10.1136/bmjopen-2016-011088.
  • Solanki PA, Ko NY, Qato D, Calip GS. Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991-2011.. SpringerPlus. 2016;5:82. doi:10.1186/s40064-016-1726-3.
  • Tinto H, Sevene E, Dellicour S, Calip GS, d’Alessandro U, Macete E, Nakanabo-Diallo S, Kazienga A, Valea I, Sorgho H, Valá A, Augusto O, Ruperez M, Menendez C, Ouma P, Desai M, Ter Kuile F, Stergachis A. Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.. Reproductive health. 2015;12:112. doi:10.1186/s12978-015-0101-0.
  • Dellicour S, Desai M, Aol G, Oneko M, Ouma P, Bigogo G, Burton DC, Breiman RF, Hamel MJ, Slutsker L, Feikin D, Kariuki S, Odhiambo F, Pandit J, Laserson KF, Calip GS, Stergachis A, ter Kuile FO. Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya.. Malaria journal. 2015;14:461. doi:10.1186/s12936-015-0950-6.
  • Calip GS, Malmgren JA, Lee WJ, Schwartz SM, Kaplan HG. Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer.. Breast cancer research and treatment. 2015;154(1):133-43. doi:10.1007/s10549-015-3590-1.
  • Calip GS, Yu O, Hoskins KF, Boudreau DM. Associations between diabetes medication use and risk of second breast cancer events and mortality.. Cancer causes & control : CCC. 2015;26(8):1065-77. doi:10.1007/s10552-015-0599-z.
  • Kaplan HG, Malmgren JA, Atwood MK, Calip GS. Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007.. Cancer. 2015;121(15):2553-61. doi:10.1002/cncr.29371.
  • Calip GS, Law EH, Ko NY. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.. Breast cancer research and treatment. 2015;151(3):687-96. doi:10.1007/s10549-015-3439-7.
  • Calip GS, Hubbard RA, Stergachis A, Malone KE, Gralow JR, Boudreau DM. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.. Pharmacoepidemiology and drug safety. 2015;24(1):75-85. doi:10.1002/pds.3660.
  • Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM. Metabolic syndrome and outcomes following early-stage breast cancer.. Breast cancer research and treatment. 2014;148(2):363-77. doi:10.1007/s10549-014-3157-6.
  • Kaplan HG, Malmgren JA, Li CI, Calip GS. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.. Breast cancer research and treatment. 2013;142(3):629-36. doi:10.1007/s10549-013-2773-x.
  • Monahan LJ, Calip GS, Novo PM, Sherstinsky M, Casiano M, Mota E, Dourado I. Impact of the Family Health Program on gastroenteritis in children in Bahia, Northeast Brazil: an analysis of primary care-sensitive conditions.. Journal of epidemiology and global health. 2013;3(3):175-85. doi:10.1016/j.jegh.2013.03.002.
  • Calip GS, Boudreau DM, Loggers ET. Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment.. Breast cancer research and treatment. 2013;138(1):225-33. doi:10.1007/s10549-013-2424-2.
  • Calip GS, McDougall JA, Wheldon MC, Li CI, De Roos AJ. Evaluation of seasonality in the diagnosis of acute myeloid leukaemia among adults in the United States, 1992-2008.. British journal of haematology. 2013;160(3):343-50. doi:10.1111/bjh.12137.
  • Schenk JM, Calip GS, Tangen CM, Goodman P, Parsons JK, Thompson IM, Kristal AR. Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 2012;176(2):156-63. doi:10.1093/aje/kwr524.
  • Shelley D, Anno J, Tseng TY, Calip GS, Wedeles J, Lloyd M, Wolff MS. Implementing tobacco use treatment guidelines in public health dental clinics in New York City.. Journal of dental education. 2011;75(4):527-33.
  • Education

  • Other, Postdoctoral Fellowship, Cancer Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA
  • PhD, Epidemiology, University of Washington, Seattle, WA
  • Other, MPH, Biostatistics & Epidemiology, New York University, New York, NY
  • PharmD, Pharmacy, University of Illinois at Chicago, Chicago, IL
  • Professional Memberships

  • American Society of Hematology
  • American Association for Cancer Research
  • American Society of Clinical Oncology
  • International Society for Pharmacoepidemiology